Victory Capital Management Inc. Purchases 124,404 Shares of AdaptHealth Corp. (NASDAQ:AHCO)

Victory Capital Management Inc. lifted its position in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 727.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 141,507 shares of the company’s stock after purchasing an additional 124,404 shares during the period. Victory Capital Management Inc. owned about 0.11% of AdaptHealth worth $1,589,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in AHCO. Vanguard Group Inc. grew its holdings in AdaptHealth by 8.9% during the 1st quarter. Vanguard Group Inc. now owns 10,017,722 shares of the company’s stock worth $115,304,000 after acquiring an additional 818,241 shares during the last quarter. Reinhart Partners LLC. grew its stake in shares of AdaptHealth by 45.2% in the third quarter. Reinhart Partners LLC. now owns 6,198,642 shares of the company’s stock worth $69,611,000 after purchasing an additional 1,929,339 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in AdaptHealth by 43.9% in the second quarter. Dimensional Fund Advisors LP now owns 2,327,738 shares of the company’s stock valued at $23,277,000 after purchasing an additional 710,131 shares during the period. Divisadero Street Capital Management LP increased its holdings in AdaptHealth by 179.7% in the second quarter. Divisadero Street Capital Management LP now owns 1,161,592 shares of the company’s stock valued at $11,616,000 after purchasing an additional 746,340 shares during the period. Finally, First Eagle Investment Management LLC raised its position in AdaptHealth by 50.9% during the 2nd quarter. First Eagle Investment Management LLC now owns 897,752 shares of the company’s stock worth $8,978,000 after purchasing an additional 302,801 shares during the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Robert W. Baird reduced their price target on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 6th. UBS Group reduced their target price on AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a report on Wednesday, November 6th. Canaccord Genuity Group decreased their target price on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, November 6th. Royal Bank of Canada dropped their price target on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 19th. Finally, Truist Financial reduced their price objective on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research note on Friday, November 15th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, AdaptHealth currently has an average rating of “Moderate Buy” and a consensus price target of $11.67.

AdaptHealth Trading Up 2.7 %

NASDAQ AHCO opened at $10.12 on Tuesday. The stock has a market capitalization of $1.36 billion, a P/E ratio of -6.13, a P/E/G ratio of 1.38 and a beta of 1.11. The business has a 50 day simple moving average of $10.47 and a 200 day simple moving average of $10.46. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. AdaptHealth Corp. has a one year low of $6.43 and a one year high of $11.90.

AdaptHealth (NASDAQ:AHCO) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $0.15 EPS for the quarter, missing the consensus estimate of $0.17 by ($0.02). The company had revenue of $805.90 million for the quarter, compared to analyst estimates of $809.32 million. AdaptHealth had a positive return on equity of 9.62% and a negative net margin of 6.57%. The business’s quarterly revenue was up .2% compared to the same quarter last year. During the same period last year, the business earned $0.19 EPS. Research analysts expect that AdaptHealth Corp. will post 0.88 earnings per share for the current year.

Insiders Place Their Bets

In related news, COO Shaw Rietkerk sold 25,000 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $11.24, for a total transaction of $281,000.00. Following the transaction, the chief operating officer now directly owns 212,611 shares of the company’s stock, valued at approximately $2,389,747.64. This represents a 10.52 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director David Solomon Williams III sold 4,000 shares of the stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $11.26, for a total value of $45,040.00. Following the completion of the transaction, the director now owns 36,899 shares in the company, valued at approximately $415,482.74. The trade was a 9.78 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 4.43% of the company’s stock.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.